The agonistic activity of IgG2 antibodies depends, in part, on the flexibility of their hinge region, which is slow to measure in full-length antibodies. Here, the authors develop a rapid mass spectrometry assay that gauges this flexibility and predicts the agonism of engineered antibody variants.